ArticleEuropean journal of obstetrics & gynecology and reproductive biology: X2026
Longitudinal study of central obesity and glucose-lipid metabolism in predicting tumor remission among fertility-sparing endometrial cancer patients.
Article in European journal of obstetrics & gynecology and reproductive biology: X, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to predict tumor remission by monitoring obesity-parameter changes during weight loss in EC patients and to identify the most reliable indicators for forecasting tumor complete remission (CR). Methods: A prospective longitudinal study was conducted to track changes in obesity parameters during a 6-month weight-loss period and to predict 9-month CR. Body morphology indicators, including weight, body mass index (BMI), waist circumference (WC), hip circumference (HC), waist-to-height ratio (WHtR), waist-to-hip ratio (WHR), lipid accumulation product (LAP), and body roundness index (BRI), and metabolic measures such as triglycerides (TG), hemoglobin A1c (HbA1c), fasting insulin (FINS), and insulin resistance (IR) were assessed. Multivariable logistic regression was used to evaluate associations between these parameters and CR, and receiver operating characteristic (ROC) analyses were performed to determine optimal cut-off values for predicting remission. Results: A total of 84 patients were included. Multivariable logistic regression identified WHR as a significant independent predictor for CR (P = 0.015, OR=1.111 95% CI: 1.021-1.209). ROC analysis revealed optimal cut-off values for WHR (0.90), TG (1.38), and FINS (18.93). The AUC values were 0.71, 0.63, and 0.67 respectively, indicating moderate predictive value. Calibration and decision curve analyses confirmed the models' stability and clinical benefit. Conclusions: WHR may serve as an additional predictor of obesity in CR. of obesity for CR. It is a convenient and quick method for monitoring and developing individualized treatments for fertility preservation and weight reduction strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.